These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 31830749)
1. Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population. Khan NI; Saherwala AA; Chen M; Salehian S; Salahuddin H; Welch BG; Pinho MC; Shang T Cerebrovasc Dis Extra; 2019; 9(3):139-147. PubMed ID: 31830749 [TBL] [Abstract][Full Text] [Related]
2. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors. Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053 [TBL] [Abstract][Full Text] [Related]
3. High Prevalence of Moyamoya Syndrome in Appalachia. Nisiewicz MJ; Roberts JM; Dobbs MR; Ajadi EA; Kitzman P; Wolfe M; Elkins K; Dugan AJ; Fraser JF Cerebrovasc Dis; 2020; 49(5):516-521. PubMed ID: 33027801 [TBL] [Abstract][Full Text] [Related]
5. Association of apolipoprotein E gene polymorphism with small-vessel lesions and stroke type in moyamoya disease: a preliminary study. Jang DK; Huh PW; Lee KS J Neurosurg; 2016 Jun; 124(6):1738-45. PubMed ID: 26566210 [TBL] [Abstract][Full Text] [Related]
6. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China. Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267 [TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and Natural History of Quasi-Moyamoya Disease. Zhao M; Lin Z; Deng X; Zhang Q; Zhang D; Zhang Y; Wang R; Wang S; Jiang Z; Wang H; Zhao J J Stroke Cerebrovasc Dis; 2017 May; 26(5):1088-1097. PubMed ID: 28109734 [TBL] [Abstract][Full Text] [Related]
8. Asymptomatic cerebral microbleeds in adult patients with moyamoya disease: a prospective cohort study with 2 years of follow-up. Sun W; Yuan C; Liu W; Li Y; Huang Z; Zhu W; Li M; Xu G; Liu X Cerebrovasc Dis; 2013; 35(5):469-75. PubMed ID: 23736000 [TBL] [Abstract][Full Text] [Related]
9. Microbleed Status and 3-Month Outcome After Intravenous Thrombolysis in 717 Patients With Acute Ischemic Stroke. Turc G; Sallem A; Moulin S; Tisserand M; Machet A; Edjlali M; Baron JC; Leclerc X; Leys D; Mas JL; Cordonnier C; Oppenheim C Stroke; 2015 Sep; 46(9):2458-63. PubMed ID: 26230857 [TBL] [Abstract][Full Text] [Related]
10. Prevalence and Associated Risk Factors of Cerebral Microbleeds in Egyptian Patients with Acute Ischemic Stroke and Atrial Fibrillation. Elkhatib THM; Elsaid AF; Al-Molla RM; Khamis MEM; Fahmi RM J Stroke Cerebrovasc Dis; 2020 May; 29(5):104703. PubMed ID: 32111450 [TBL] [Abstract][Full Text] [Related]
11. Difference in Cerebral Circulation Time between Subtypes of Moyamoya Disease and Moyamoya Syndrome. Kang K; Lu J; Zhang D; Li Y; Wang D; Liu P; Li B; Ju Y; Zhao X Sci Rep; 2017 May; 7(1):2587. PubMed ID: 28566764 [TBL] [Abstract][Full Text] [Related]
12. Epidemiological and clinical features of moyamoya disease in the USA. Kainth D; Chaudhry SA; Kainth H; Suri FK; Qureshi AI Neuroepidemiology; 2013; 40(4):282-7. PubMed ID: 23445954 [TBL] [Abstract][Full Text] [Related]
13. Disparities in the symptomatic presentation of Moyamoya disease in the United States: A nationwide all-payer analysis. Fuentes AM; Chiu RG; Mehta AI J Clin Neurosci; 2021 May; 87():92-96. PubMed ID: 33863543 [TBL] [Abstract][Full Text] [Related]
14. Long-Term Prognostic Implications of Cerebral Microbleeds in Chinese Patients With Ischemic Stroke. Lau KK; Wong YK; Teo KC; Chang RSK; Tse MY; Hoi CP; Chan CY; Chan OL; Cheung RHK; Wong EKM; Kwan JSK; Hui ES; Mak HKF J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29217662 [TBL] [Abstract][Full Text] [Related]
15. Spatial relationship between cerebral microbleeds, moyamoya vessels, and hematoma in moyamoya disease. Kazumata K; Shinbo D; Ito M; Shichinohe H; Kuroda S; Nakayama N; Houkin K J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1421-8. PubMed ID: 24529354 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Stroke Risk Factors between Symptomatic and Asymptomatic Patients in a North American Moyamoya Disease Cohort. Kumar M; Larson A; Jabal MS; Rinaldo L; Savastano L; Lanzino G; Meyer F; Lehman V; Klaas J Cerebrovasc Dis Extra; 2022; 12(2):72-75. PubMed ID: 35588715 [TBL] [Abstract][Full Text] [Related]
17. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia. Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391 [TBL] [Abstract][Full Text] [Related]
18. Predictors of cerebral microbleeds in acute ischemic stroke and TIA patients. Ovbiagele B; Saver JL; Sanossian N; Salamon N; Villablanca P; Alger JR; Razinia T; Kim D; Liebeskind DS Cerebrovasc Dis; 2006; 22(5-6):378-83. PubMed ID: 16888379 [TBL] [Abstract][Full Text] [Related]
19. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China. Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868 [TBL] [Abstract][Full Text] [Related]
20. Predictors of New Cerebral Microbleeds in Patients with Antiplatelet Drug Therapy. Wobith M; Mayer C; Belke M; Haag A; Gerstner A; Teepker M; Strzelczyk A; Werner R; Hamer HM; Rosenow F; Menzler K; Knake S J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1671-1677. PubMed ID: 27067881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]